Improving the understanding and management of late-effects in adolescents and young adults (AYA) with cancer

Last updated: 16.7.2025
Grant

This program, part of the Horizon Europe Mission on Cancer, focuses on improving the understanding and management of late-effects in adolescents and young adults (AYA) with cancer. It aims to significantly enhance the quality of life for survivors aged 15-39 by fostering collaborative research and implementing innovative, holistic approaches to cancer treatment and follow-up regimens.

Who is Funded

The program targets a diverse range of organizations and entities involved in health, research, and innovation across EU Member States and Associated Countries. Its primary objective is to improve the lives of adolescent and young adult cancer patients and survivors by addressing the long-term effects of their treatments.

What is Funded

This funding initiative supports research and innovation actions focused on understanding, detecting, and managing the long-term effects of cancer treatments in adolescents and young adults. The scope includes diverse thematic areas from advanced medical research to digital health solutions, aiming to improve survivors' quality of life.

Type and Scope of Funding

The program provides significant grant funding for collaborative projects. The total budget available is substantial, with individual grants expected to fall within a specified range.

Conditions and Requirements

Applicants must adhere to general Horizon Europe conditions and specific program requirements. Collaboration within consortia is mandatory, and projects are encouraged to align with existing EU initiatives related to cancer care and quality of life.

Application Procedure

The application process for this program involved a single-stage submission. Proposals were rigorously evaluated based on specific criteria and thresholds, with a unique ranking mechanism to ensure a balanced portfolio of funded projects.

The funding program is firmly rooted in established EU legal frameworks, primarily under Horizon Europe, ensuring its legitimacy and guiding its operational and financial management.

Similar Programs

#AYA Cancer Late-Effects#Horizon Europe Cancer Mission#Adolescent Young Adult Cancer#Cancer Survivorship Research#Quality of Life Cancer#Cancer Treatment Late Effects#EU Health Funding#HORIZON-MISS-2024-CANCER-01-05#Cancer Patient Care#Digital Health Cancer#Medical Innovation Europe#Collaborative Cancer Research#Public Health Initiatives#Health Technology Assessment#AI in Cancer Care#European Research Grants#Cancer Prevention Strategies#Childhood Cancer Survivors#Mental Health Cancer

Funding Overview

Funding Status

Funding Status:

Closed

Maximum Amount

Maximum Amount:

6,000,000 EUR

Allocated Budget

Allocated Budget:

36,000,000.00 EUR

Award Channel

Award Channel:

Framework Programme Call

Region

Region:

European Union and Associated Countries

Sectors

Sectors:

Healthcare, Research and Development, Medical Technology, Information and Communication Technology, Software Development

Beneficiaries

Beneficiaries:

Adolescents and young adults (AYA) cancer patients and survivors (age range 15-39), their caregivers and families.

Application Type

Application Type:

Consortium Required

Funding Stages

Funding Stages:

Applied Research, Experimental Development, Product Development, Process Optimization, Implementation, Service Delivery

Funding Provider

Program Level:

European Union

Funding Body:

European Commission

0 x 0
XS